Wellington Management Group
ANTH

Wellington Management Group’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Wellington Management Group’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-29,181
Closed -$1.08M – 2290
2015
Q4 		$1.08M Buy
29,181
+15,443
+112% +$682K ﹤0.01% 1809
2015
Q3 		$669K Buy
+13,738
New +$960K ﹤0.01% 1911

Other funds holding ANTH

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Wellington Management Group's ANTH Position: Q1 2016 in Review

Wellington Management Group sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q1 2016, closing a stake of 29,181 shares — an estimated $1.08M sold.

Wellington Management Group first reported a position in ANTH in Q3 2015 and held it in 2 quarters. The position peaked at $1.08M in Q4 2015. 72 funds tracked by Wall St. Rank hold ANTH as of Q1 2016.

  • Wellington Management Group reported no remaining Anthera Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
  • Wellington Management Group sold 29,181 Anthera Pharmaceuticals, Inc. shares in Q1 2016, an estimated $1.08M.
  • Wellington Management Group first reported a position in Anthera Pharmaceuticals, Inc. in Q3 2015 and held it in 2 quarters.
  • Wellington Management Group's Anthera Pharmaceuticals, Inc. position peaked at $1.08M in Q4 2015.
  • 72 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q1 2016.

Based on Wellington Management Group's 13F filing for Q1 2016, filed 13 May 2016.